The U.S. push to isolate Iran has intensified challenges for the country in obtaining essential medicines, as international sanctions and trade restrictions tighten access to critical pharmaceutical supplies. With global supply chains increasingly disrupted by geopolitical tensions, Iranian health authorities face growing difficulties in sourcing lifesaving drugs and medical equipment. The situation underscores broader concerns about how economic pressures can impact public health in nations already strained by sanctions. Experts warn that prolonged restrictions could worsen healthcare disparities and leave vulnerable populations without adequate treatment.
Washington’s campaign to isolate the Islamic republic has made securing pharmaceuticals increasingly difficult
